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imitation of Exercise Tolerance in
hronic Heart Failure: Distinct Effects of Left
undle-Branch Block and Coronary Artery Disease
lison M. Duncan, MB, BS, Darrel P. Francis, MD, Derek G. Gibson, FRCP,
ichael Y. Henein, MD, PHD, FACC
ondon, United Kingdom
OBJECTIVES The aim of this study was to identify resting measurements of left ventricular (LV) function
that predict exercise capacity in dilated cardiomyopathy (DCM); in particular, the effects of
left bundle branch block (LBBB), coronary artery disease (CAD), and total isovolumic time
(t-IVT).
BACKGROUND The t-IVT is a major determinant of cardiac output during dobutamine stress in DCM, and
is itself determined by the presence or absence of LBBB and CAD.
METHODS A total of 111 patients with DCM, 51 with CAD (29 LBBB), and 60 without CAD (30
LBBB) were studied with echocardiography and cardiopulmonary exercise testing. The t-IVT
(in s/min) was measured by Doppler echocardiography, and maximal oxygen consumption
(peak VO2) and percentage of the normal predicted peak VO2 (%predicted peak VO2) were
obtained from exercise testing.
RESULTS Left bundle branch block reduced peak VO2 (by 10.5 ml·kg
1min1) and %predicted peak
VO2 (by 33%, both p  0.001) compared with patients without LBBB. Coronary artery
disease reduced peak VO2 (by 5.5 ml·kg
1min1, p  0.001) and %predicted peak VO2 (by
14%, p  0.01) compared with those without CAD (p  0.01). The t-IVT, CAD, LBBB,
and QRS duration were univariate predictors of exercise tolerance, but only t-IVT and CAD
were independent predictors. The t-IVT at rest correlated with peak VO2 (r  0.68) and
%predicted peak VO2 (r  0.74, both p  0.001). The combination of t-IVT and CAD
explained 57% (r  0.75, p  0.001) of the total variance in exercise capacity.
CONCLUSIONS Resting t-IVT and less prominently, CAD, are major determinants of exercise tolerance in
DCM. Left bundle branch block significantly determines resting t-IVT and thus peak VO2.
Prediction of maximum exercise capacity in DCM is therefore possible from time-domain
analysis of LV function at rest. (J Am Coll Cardiol 2004;43:1524–31) © 2004 by the
American College of Cardiology Foundation(
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(he clinical syndrome of heart failure is associated with
mpaired exercise tolerance (1), though the factors limiting
xercise capacity remain a matter of debate (2); in particular,
jection fraction (EF), the conventional measurement of
esting left ventricular (LV) function, does not predict
xercise tolerance (assessed by peak exercise capacity [peak
O2]) in patients with dilated cardiomyopathy (DCM)
3,4).
See page 1532
Total isovolumic time (t-IVT) at peak stress (the time, in
econds per minute, when the ventricle is neither ejecting
or filling), and thus the Tei index, which effectively
ncludes it (5), has been found to be a major determinant of
aximum cardiac output during dobutamine stress in pa-
ients with DCM (6). The t-IVT itself is largely determined
y the presence or absence of two factors, namely coronary
rtery disease (CAD) and left bundle-branch block (LBBB)
From the Department of Echocardiography, The Royal Brompton Hospital,
ondon, United Kingdom. Dr. Duncan is supported by The Garfield Weston Trust.dManuscript received September 19, 2003; accepted October 15, 2003.7). We hypothesized that the presence or absence of CAD
nd LBBB might also predict maximum exercise capacity in
atients with DCM. In addition, we investigated the
ossibility that resting t-IVT would provide an echocardio-
raphic marker that might predict peak VO2 in these
atients.
ETHODS
atients. We analyzed data from 111 patients with systolic
eart failure who had undergone clinically indicated cardio-
ulmonary exercise testing in the period 1999 to 2002 at the
oyal Brompton Hospital. All had undergone routine
esting echocardiography within two months of exercise
esting. Systolic heart failure was diagnosed on the basis of
history of limitation of exercise tolerance by fatigue or
reathlessness and evidence of LV systolic dysfunction on
chocardiography (defined as LV end-diastolic dimension
56 mm and end-systolic dimension 40 mm on an
-mode echocardiogram, and an EF 40%). Significant
AD was demonstrated by at least two-vessel disease
70% stenosis) at coronary angiography, and LBBB was
iagnosed on the basis of a QRS duration 120 ms, absent
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onophasic QS or rS waves in V1 and V2. Predetermined
riteria for exclusion were patients with atrial fibrillation,
tructural valve disease, or more than mild functional mitral
egurgitation. The patients were closely monitored by a
eart failure research nurse, and those who developed
ignificant deterioration in clinical status, change in therapy
r electrocardiogram between exercise testing and echocar-
iography were excluded from the study. For reference, 15
ge-matched control subjects were also included, none of
hom had symptoms or signs of heart failure or evidence of
V dysfunction on echocardiography.
chocardiography. Transthoracic echocardiography was
erformed using a Phillips Sonos 5500 echocardiograph
Andover, Massachusetts) and a multifrequency transducer.
esting cross-sectional, two-dimensional guided M-mode
ecordings of the LV minor axis were performed using the
eft parasternal long-axis view with the cursor at the tips of
he mitral valve leaflets. The LV minor axis dimensions
ere taken at end-diastole (the onset of the QRS complex)
nd at end-systole (at the first high-frequency vibration of
he aortic component of the second heart sound on the
honocardiogram, A2) using leading edge methodology. A2
as confirmed as being synchronous with the onset of the
losure artifact on the aortic Doppler record. The left
entricular ejection fraction (LVEF) was obtained using
iplane Simpson’s methodology (8). Fractional shortening
as calculated as the percentage fall in LV cavity dimension
uring systole with respect to that in diastole. Mean velocity
f circumferential fiber shortening rate (Vcf) was calculated
s1) as the ratio of fractional shortening to LV ejection
ime.
Transaortic flow velocity was obtained from the apical
ve-chamber view. The LV ejection time was measured as
he interval between the onset of forward aortic flow to the
Abbreviations and Acronyms
CAD  coronary artery disease
CV  coefficient of variation
DCM  dilated cardiomyopathy
E/A ratio  ratio of early transmitral flow
velocity to atrial flow velocity
EF  ejection fraction
F  variance ratio
LBBB  left bundle branch block
LV  left ventricular
LVEF  left ventricular ejection fraction
peak VO2  peak exercise capacity
%predicted peak VO2  percentage of the normal
predicted peak VO2
RMS  root mean square
t-IVT  total isovolumic time
Vcf  mean velocity of circumferential
fiber shortening rate
VCO2  carbon dioxide production
VE  minute ventilationnset of the aortic valve closure artifact. Transmitral Dopp- Per flow velocities were recorded from the apical four-
hamber view, and peak E (early diastolic) and A (atrial)
elocities were measured. Filling time was measured from
he onset of the E wave to the end of the A wave. Total LV
jection and filling periods were derived as the product of
he corresponding time interval and heart rate and expressed
n seconds per minute (s/min). Total isovolumic time, also
n s/min, was calculated as [60 (total ejection time total
lling time)] (Fig. 1). These values are independent of
esting heart rate (9). The Tei index was calculated as the
um per beat of isovolumic contraction and isovolumic
elaxation times, divided by ejection time (5). Potential
itral regurgitation was graded using standard criteria:
ild, moderate, or severe, according to the distance from
he valve orifice that the regurgitant jet remained detectable
n the color flow Doppler recording (10). All tracings were
cquired at a paper speed of 100 mm/s, with an electrocar-
iogram (lead II) and a phonocardiogram superimposed.
ardiopulmonary exercise testing. All patients underwent
ymptom-limited cardiopulmonary exercise testing (modi-
ed Bruce protocol) with assessment of minute ventilation
VE), oxygen consumption (VO2), and carbon dioxide pro-
uction (VCO2) every 10 s by mass spectrometer (Amis
000, Innovision; MedGraphics Cardio O2 System,
dense, Denmark). Patients were encouraged to exercise to
xhaustion (VCO2/VO21.05). Continuous 12-lead electro-
ardiographic monitoring was used. All participants stopped
xercise because of breathlessness and/or fatigue. None
xperienced chest pain or developed ST segment shift.
igure 1. Measurement of total isovolumic time (t-IVT) in a patient with
ilated cardiomyopathy (aortic and mitral Doppler recordings superim-
osed). Total ejection time (ET) and total filling time (FT) are derived as
he product of the corresponding time interval and heart rate, expressed in
/min. The t-IVT is then calculated as [60  (total ejection time  total
lling time)]. ET  320 ms or 0.32  63  20 s/min. FT  500 ms or
.50  63  32 s/min. t-IVT  60 – (20  32)  8 s/min. ECG 
lectrocardiogram; PCG  phonocardiogram.redicted peak VO2 was calculated on the basis of gender,
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Limitation of Exercise Tolerance in Heart Failure May 5, 2004:1524–31ge, and weight. Peak VO2 was expressed in milliliters per
ilogram per minute and also as a percentage of the normal
redicted peak VO2 (%predicted peak VO2) (11). The slope
f the relationship between VE and VCO2 (VE/VCO2) was
alculated as the index of ventilatory response to exercise
12).
ata analysis. Statistical calculations were performed us-
ng the Statview 4.5 package (Abacus Concepts, Berkeley,
alifornia). Numerical values are expressed as mean  SD.
n unpaired Student t test was used to compare values
etween subgroups of patients with DCM. A two-way
nalysis of variance, which considered all the patients as a
ingle group, was used to identify the individual contribu-
ions of CAD and LBBB to resting echo values and to
xercise variables. The incremental value of CAD, LBBB
both either present or absent), QRS duration, t-IVT, and
ei index were tested using a multiple regression analysis,
sing a variance ratio (F) 6 as the criterion for entry into
he multivariate analysis. Correlation was performed by
inear regression analysis. In view of multiple statistical tests,
significant difference was taken as p  0.01.
eproducibility. Interobserver variability was assessed by
wo investigators, both unaware of the original diagnosis
nd of the other’s finding. Duplicate measurements of total
jection and total filling times in 20 patients were obtained
rom the same original records. Reproducibility was ex-
ressed as the root mean square (RMS) difference between
uplicate values and as a coefficient of variation (CV). The
nterobserver RMS difference for total ejection time was 0.8
/min (CV 4.2%) and 1.9 s/min for total filling time (CV
.4%). To exclude any significant beat-to-beat variation in
eart rate between recordings of mitral inflow and LV
utflow in determining t-IVT, the reproducibility of RR
nterval at the time of measuring LV filling and ejection
imes was assessed, again in 20 patients. The interobserver
MS difference for RR interval was 20 ms (CV 2.4%).
able 1. Echocardiographic Variables at Rest
Variable
Control
(n  15)
No CAD, No LBBB
(n  30)
DD (mm) 48  4 66  7
SD (mm) 29  5 53  9
F (%) 75  8 31  4
cf (circ/s) 1.44  3.9 0.8  0.3
/A ratio 1.0  0.3 1.8  1.5
R (beats/min) 76  12 76  17
-ET (s/min) 20  2 19  3
-FT (s/min) 28  3 30  3
-IVT (s/min) 12  2 11  2
ei index 0.6  0.1 0.6  0.2
alues are mean  SD. CAD (no LBBB) versus no CAD (no LBBB): all p  NS. *p
AD (no LBBB). ‡p  0.01, CAD (LBBB) versus no CAD (LBBB).
CAD  coronary artery disease; E/A ratio  ratio of early transmitral flow veloc
end-systolic dimension; HR  heart rate; LBBB  left bundle branch block; t-E
ean velocity of circumferential fiber shortening.eproducibility of peak VO2 in a similar group of patients tas previously been reported from this institution (difference
etween 2 tests: 0.93 ml·g1·min1; SD of the difference:
.07 ml·kg1·min1; coefficient of variability: 17.5%) (13).
ESULTS
ubjects. Of 111 patients studied, 94 were male (age 57 
3 years). Fifty-one patients had significant CAD, 22 with
ormal activation (QRS duration 97  9 ms) and 29 with
BBB (QRS 160  24 ms). Coronary angiography was
ormal in 60 patients, 30 with normal activation (QRS
uration 97  10 ms) and 30 with LBBB (QRS duration
46  27 ms, p  NS compared with those with CAD).
here were no significant differences in medical therapy
etween patient groups. In those with no CAD, 25 of 60
ere receiving a beta-blocking agent, 56 an angiotensin-
onverting enzyme inhibitor, and 58 a diuretic. In patients
ith CAD, 28 of 51 patients were receiving a beta-blocking
gent, 51 an angiotensin-converting enzyme inhibitor, and
7 a diuretic. The median time interval between resting
chocardiography and cardiopulmonary exercise testing,
alculated irrespective of which test was performed first, was
wo days (interquartile range 0 to 21 days).
chocardiographic data at rest in DCM. In patients,
nd-diastolic dimension was 69  9 mm, end-systolic
imension 57  10 mm, EF 34  5%, and Vcf 7.2  2.5
1 (all p  0.001 compared with control subjects). There
as no difference in the severity of LV dysfunction within
atient subgroups in terms of LV cavity dimensions, LVEF,
cf, or the ratio of early transmitral flow velocity to atrial
ow velocity (E/A ratio) (Table 1), nor in terms of mitral
egurgitation (mild mitral regurgitation was present in 21
atients with no CAD nor LBBB, 14 with CAD alone, 26
ith LBBB alone, and 23 patients with both CAD and
BBB). There was also no difference in resting t-IVT
etween patients with or without CAD compared with
ontrol subjects, provided activation was normal. However,
Dilated Cardiomyopathy
AD, No LBBB
(n  22)
No CAD, LBBB
(n  30)
CAD and LBBB
(n  29)
67  6 70  9 71  9
55  7 59  11 59  10
33  5 31  5 31  6
0.7  0.2 0.7  0.3 0.7  0.2
1.9  1.6 2.6  1.0 1.9  1.3
73  13 83  16 73  13
19  2 19  3 17  3
28  3 20  3* 23  5†‡
13  2 21  3* 20  4†
0.7  0.2 1.2  0.3* 1.2  0.3†
01, no CAD (LBBB) versus no CAD (no LBBB). †p  0.001, CAD (LBBB) versus
atrial flow velocity; EDD  end-diastolic dimension; EF  ejection fraction; ESD
otal ejection time; t-FT  total filling time; t-IVT  total isovolumic time; Vcf C
 0.0
ity to
T  t-IVT at rest was significantly prolonged in patients with
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/min, F  208, p  0.001), whether or not CAD was
resent (Table 1), primarily as a result of shortening of total
lling time (by 8 s/min, F 101, p 0.001). Similarly, Tei
ndex was normal in patients with or without CAD pro-
ided activation was normal, but was increased in patients
ith LBBB (by 0.52, F  112, p  0.001), irrespective of
hether CAD was present or absent.
ardiopulmonary exercise testing. There were significant
ifferences in exercise tolerance within patient subgroups
Table 2).
ATIENTS WITH NEITHER CAD NOR LBBB. These patients
ad the highest values for peak VO2 and %predicted peak
O2 compared with other patient subgroups (Fig. 2),
lthough the values were less than normal in each case (by
2.7 ml·kg1min1 and by 30%, both p  0.001 compared
ith control subjects).
able 2. Cardiopulmonary Exercise Testing
Variable
Control
(n  15)
No CAD, No LBB
(n  30)
eak VO2 (ml·kg
1 min1) 38.4  8.4 26.2  5.9*
predicted peak VO2 115  13 85  15*
ER (VCO2/VO2) 1.09  0.76 1.13  0.12*
E/VCO2 slope 24.9  3.4 29.2  6.8
alues are mean  SD. *p  0.001, no CAD (no LBBB) versus control subjects. †p
LBBB) versus no CAD (no LBBB). p  0.01, ¶p  0.001, CAD (LBBB) versus
CAD  coronary artery disease; LBBB  left bundle branch block; RER  resp
entilation; peak VO2  peak oxygen uptake.
igure 2. Percentage predicted peak exercise capacity (VO2) in individual pa
CAD) nor left bundle branch block (LBBB) had the highest values for %
ith LBBB had the lowest values of all, irrespective of whether CAD was presAD, NO LBBB. Peak VO2 and %predicted peak VO2 were
ower in patients with CAD compared with those with no
AD (by 5.5 ml·kg1min1, p  0.001, and by 14%, p 
.01, respectively).
BBB, NO CAD. Peak VO2 and %predicted peak VO2 were
ignificantly lower (by 10.5 ml·kg1min1 and by 33%), and
E/VCO2 slope was increased (by 13.4, all p  0.001) in
atients with LBBB compared with those with normal
ctivation.
AD AND LBBB. Peak VO2 and %predicted peak VO2 were
educed (Fig. 2), and VE/VCO2 slope was increased, in
atients with both CAD and LBBB compared with CAD
lone (by 6.2 ml·kg1min1, 21%, and 8.8, respectively, all
 0.001). There was no significant difference in any
xercise variable between patients with CAD and LBBB
ompared with LBBB alone.
Dilated Cardiomyopathy
CAD, No LBBB
(n  22)
No CAD, LBBB
(n  30)
CAD and LBBB
(n  29)
20.7  4.7‡ 15.6  4.8§ 14.4  3.5¶
71  17† 52  16§ 50  13¶
1.06  0.10 1.08  0.11 1.08  0.13
34.2  8.8 42.6  14.3§ 42.9  13.2
; ‡p  0.001, CAD (no LBBB) versus no CAD (no LBBB). §p  0.001, no CAD
(no LBBB). CAD (LBBB) versus no CAD (LBBB): all p  NS.
exchange ratio at peak exercise; VCO2  carbon dioxide production; VE  minute
with dilated cardiomyopathy. Patients with neither coronary artery disease
VO2. Coronary artery disease reduced %predicted peak VO2, but patientsB
 0.01
CAD
iratorytients
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Limitation of Exercise Tolerance in Heart Failure May 5, 2004:1524–31VERALL EFFECT OF CAD IN DCM. Coronary artery disease
educed both peak VO2 (by 3.8 ml·kg
1min1, F  13, p 
.001) and %predicted peak VO2 (by 10%, F  8, p  0.01)
ompared with patients with no CAD, irrespective of
hether LBBB was present or not, but had no significant
ffect on VE/VCO2 slope (F  0.2, p  NS).
VERALL EFFECT OF LBBB IN DCM. Left bundle branch
lock reduced peak VO2 (by 8.8 ml·kg
1min1, F 82) and
predicted peak VO2 (by 28%, F  83) compared with
atients with no LBBB, irrespective of whether CAD was
resent or absent, and increased the VE/VCO2 slope (by
1.4, F  25, all p  0.001). There was no interaction
etween CAD and LBBB.
elationship between t-IVT, Tei index, and exercise
apacity. There were significant correlations between rest-
ng t-IVT and peak VO2 (r0.68) and resting t-IVT and
predicted peak VO2 (r  0.74, Fig. 3, both p  0.001)
n patients with DCM. There was a similar correlation with
ei index at rest (r  0.70, p  0.001), but ejection time
t rest showed no correlation with %predicted peak VO2 (r
0.22, p  NS).
ndependent predictors of exercise capacity in patients
ith DCM. The t-IVT, CAD, LBBB, Tei index, and
RS duration were all univariate predictors of %predicted
eak VO2 in patients with DCM (Table 3), but in a
ultivariate analysis only t-IVT and CAD were indepen-
ent predictors of exercise capacity (LBBB, QRS duration,
nd Tei index were all subsumed by t-IVT). The combina-
ion of t-IVT and CAD explained 57% (r  0.75) of the
otal variance in %predicted peak VO2 in the overall patient
roup. There was no correlation between %predicted peak
O2 and LVEF (Fig. 3), Vcf, E/A ratio, or the presence of
ild mitral regurgitation (Table 3).
omparison with normal control subjects. In the patient
roup as a whole, peak VO2 and %predicted peak VO2 were
educed compared with control subjects (19.2  6.7
l·kg1min1 vs. 38.4 8.4 ml·kg1min1, and 64 21%
s. 115 13%, both p 0.001). A multivariate analysis was
epeated to include normal control subjects. The total
ariance in %predicted peak VO2 increased from 57% to
2% (r2  0.85, p  0.001) when DCM was included with
-IVT and CAD. Left bundle branch block, Tei index, and
RS duration were again subsumed by t-IVT.
ISCUSSION
xercise tolerance is frequently limited in patients with
ongestive heart failure, but resting ventricular function as
ssessed by EF does not predict maximum exercise capacity
3,4). This has been taken as evidence that LV function is
ot a primary determinant of peak VO2 in stable chronic
eart failure (2), so that recent attention has been diverted
o extra-cardiac abnormalities, such as disturbances in pe-
ipheral blood flow, endothelial function, skeletal muscle,
nd lung function (14–17). Indeed, higher correlations with
xercise tolerance have been found with these peripheral sbnormalities than with EF (18). Nevertheless, on an
ntuitive basis, it still seems that LV function appropriately
ssessed might be a major determinant of maximum exercise
apacity in patients with primary LV disease.
Our results confirm previous studies in demonstrating
hat variability in exercise tolerance in patients with DCM
annot be explained on the basis of either systolic (EF and
cf) or diastolic (E/A ratio) LV function. Rather, we found
hat both absolute and percentage predicted values of peak
O2 were strikingly reduced in patients with LBBB com-
ared with those without, and to a lesser extent by CAD
19), even when exercise tolerance was not limited by acute
schemia. Patients with neither LBBB nor CAD thus had
he highest absolute and percentage predicted values of peak
O2, whereas those with LBBB had the lowest values of all,
rrespective of whether CAD was present or not. Even when
BBB and CAD were allowed for, resting t-IVT, a simple
cho-derived measurement, had additional predictive value.
RS duration varied over a wide range, but provided no
nformation additional to that derived from the simple
resence or absence of LBBB. The Tei index predicted
xercise tolerance, but only because it included t-IVT in its
erivation. Ejection time, the second component of the Tei
ndex, was of no predictive value on its own; its inclusion did
ot increase the predictive value of the Tei index above that
f t-IVT alone, and it was eliminated by t-IVT in multi-
ariate analysis as an independent predictor of peak VO2.
echanisms. Prolongation of t-IVT proved a major de-
erminant of exercise capacity. It is likely that this prolon-
ation was due to ventricular asynchrony, which in LBBB is
he result of abnormal activation causing dispersion in the
iming of local systole and diastole (20). However, despite
he overwhelming effect of LBBB on resting t-IVT, the
resence of CAD still remained a highly significant deter-
inant of peak VO2. The reason for this was not clear,
ecause CAD was without significant effect on resting
-IVT. Although its effect during exercise may be the result
f some other mechanism, the association is compatible
ith the idea that CAD prolongs t-IVT on exercise though
ot at rest.
The present results have many features in common to
hose recorded during pharmacologic stress with dobut-
mine. In both circumstances, t-IVT was a major determi-
ant of peak cardiac output, and was itself determined by
oth LBBB and CAD, though the effect of the latter was
pparent only during stress (6). If CAD showed similar
ivergence in its effects between rest and muscular exercise,
t would explain how it might remain independent of resting
-IVT in predicting peak VO2, as in our present findings.
owever, there are significant differences between cardio-
ulmonary exercise testing and dobutamine stress. It was
nly peak stress t-IVT, not resting t-IVT, that predicted
eak cardiac output during stress. In addition, the effects of
AD and LBBB appeared to be independent during
obutamine stress, so that when both were present, peak
tress cardiac output was lower than with either alone.
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May 5, 2004:1524–31 Limitation of Exercise Tolerance in Heart Failurehese findings underline that although erect muscular
xercise and pharmacologic stress have similar effects on
ardiac function, they are not identical, and findings from
ne cannot always be extrapolated directly to the other.
ractical implications. The results from our study suggest
hat asynchrony, rather than uniform depression of systolic
r diastolic ventricular function, prolongs the total isovolu-
igure 3. (Top) Correlation between resting total isovolumic time (t-IVT)
ere considered as a single group, resting t-IVT correlated closely with %
ongest t-IVT at rest and the lowest %predicted peak VO2, irrespective of w
etween left ventricular ejection fraction and %predicted peak VO2.ic period within the cardiac cycle, and that it is this rsynchrony that is the significant factor in determining
aximum exercise tolerance in patients with DCM and
eart failure. Our study thus re-emphasizes that LV func-
ion is important in the genesis of the clinical syndrome of
eart failure but that indices of LV asynchrony need to be
ssessed if this relationship is to be demonstrated. Time-
omain analysis of LV function is simple and highly
ercentage predicted peak exercise capacity (VO2). When individual patients
icted peak VO2. Patients with left bundle branch block (LBBB) had the
r coronary artery disease (CAD) was present. (Bottom) Lack of correlationand p
pred
hetheeproducible, and should be included in the assessment of
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uch as EF, wall stiffness, or rates of change of pressure,
hich take no account of regional heterogeneity. Further-
ore, our results might explain the limited value of positive
notropic agents (21), whose effects may be modified in
atients with heterogeneous LV disease. Peak oxygen up-
ake, VE/VCO2 slope, and QRS duration have all been used
o predict survival and stratify risk in patients with chronic
eart failure (22,23). Future studies may determine whether
esting t-IVT can be used in the same way.
tudy limitations. This was a retrospective study of pa-
ients with a clinical diagnosis of heart failure referred to a
ertiary referral center. The time-related variables chosen to
redict maximum exercise capacity in patients with DCM
ere pre-specified from previous studies using dobutamine
tress (6), and therefore the present results need not be
egarded as a learning set. The time interval of up to two
onths between exercise testing and echocardiography in a
inority of patients may well have introduced additional
andom variance into estimates of t-IVT, but 50% of the
atient population underwent both tests within a two-day
eriod, and in all cases, electrocardiographic analysis was
ynchronous with exercise testing. However, to elucidate the
xact relationship between LBBB and exercise capacity will
equire verification in a prospective investigation that con-
ucts both studies on the same day. In common with
revious studies, patients with atrial fibrillation were not
ncluded, so its importance in limiting exercise tolerance was
ot determined. Although there were no significant differ-
able 3. Predictors of %Predicted VO2 max in Patients
ith DCM
Univariate Predictors of %predicted VO2 max
F Value
Correlation
Coefficient (r) p Value
-IVT (s/min) 118.4 0.74 0.001
ei index 94.6 0.70 0.001
BBB (/) 85.6 0.66 0.001
RS duration (ms) 39.7 0.52 0.001
AD (/) 6.8 0.27 0.01
/A ratio 5.3 0.24 NS
R (/) 3.6 0.18 NS
cf (s1) 3.4 0.18 NS
VEF (%) 2.0 0.14 NS
Multivariate Predictors of %predicted VO2 max
Coefficient Std. Error p Value
ntercept (%) 115.1 4.5 0.001
-IVT (s/min) 2.8 0.3 0.001
AD (/) 8.4 2.7 0.01
ei index 5.3 8.9 NS
BBB (/) 8.7 5.7 NS
RS duration (ms) 0.3 0.07 NS
AD  coronary artery disease; DCM  dilated cardiomyopathy; E/A ratio  ratio
f early transmitral flow velocity to atrial flow velocity; F  variance ratio; LBBB 
eft bundle branch block; LVEF  left ventricular ejection fraction; MR  mitral
egurgitation; t-IVT  total isovolumic time; Vcf  velocity of circumferential fiber
hortening; VO2  oxygen capacity.nces in therapeutic regimes between patient groups, theumber of patients receiving beta-blockers appeared rela-
ively low, because determination of exercise tolerance
sually preceded their up-titration. In fact, the presence or
bsence of beta-blockade proved to have no significant effect
n resting t-IVT. A subjective component in exercise
esting in patients with heart failure is well recognized, but
o qualify for inclusion, the respiratory exchange ratio at
eak exercise (VCO2/VO2) was 1.05. Finally, we did not
nvestigate extra-cardiac abnormalities, such as those in
keletal muscle blood flow, endothelial and neurohormonal
r lung function, so any additional independent contribu-
ion they might have remains uncertain.
ONCLUSIONS
imitation of exercise tolerance remains a major component
f the clinical syndrome of heart failure and causes consid-
rable deterioration in quality of life. The possibility of
uccessful treatment in individual patients is likely to be
ncreased by understanding its physiologic basis. Uniform
epression of ventricular systolic or diastolic function is not
he main limiting factor, explaining the lack of success of
reatment modalities designed on this basis. However, our
esults suggest that the left ventricle, as well as the periph-
ral circulation or neurohormonal axis, remains an appro-
riate therapeutic target, provided that asynchrony resulting
rom LBBB or CAD is addressed. Despite the technical
roblems, future studies should investigate interrelation-
hips between t-IVT and peak VO2 at the time of peak
xercise. They should also investigate how other forms of
nterventricular conduction delay or biventricular pacing
mpact on t-IVT and exercise capacity. Altering asynchrony
y manipulation of t-IVT, whether by medical, surgical, or
lectrophysiologic methods, may lead to a useful increase in
xercise tolerance in these patients.
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